Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Foundation Medicine
Related studies linked through entity extraction aliases.
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients
- Status
- SUSPENDED
- Phase
- PHASE2
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center
- Status
- UNKNOWN
- Phase
- NA
TCF-001 TRACK (Target Rare Cancer Knowledge) Study
- Status
- RECRUITING
- Phase
- NA
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
- Status
- TERMINATED
- Phase
- PHASE2
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
- Status
- COMPLETED
- Phase
- PHASE3
Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
- Status
- COMPLETED
- Phase
- PHASE2